Sio Gene Therapies Inc.
SIOX · NASDAQ
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$71,887 | -$32,425 | -$72,628 | -$129,065 |
| Dep. & Amort. | $666 | $2,466 | $3,094 | $2,450 |
| Deferred Tax | $0 | -$10,866 | -$947 | $0 |
| Stock-Based Comp. | $7,425 | $4,492 | $7,895 | $16,429 |
| Change in WC | $3,860 | -$9,474 | -$3,305 | -$19,083 |
| Other Non-Cash | -$410 | -$782 | -$1,582 | -$4,938 |
| Operating Cash Flow | -$60,346 | -$46,589 | -$67,473 | -$134,207 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$695 | -$398 | -$255 | -$202 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $4,343 | $12,784 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $3,648 | $12,386 | -$255 | -$202 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,441 | $89,231 | $70,810 | $94,549 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,441 | $73,621 | $41,481 | $87,071 |
| Financing Cash Flow | $1,441 | $73,621 | $41,481 | $87,071 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$55,257 | $39,418 | -$26,247 | -$47,338 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $120,170 | $80,752 | $106,999 | $154,337 |
| End Cash | $64,913 | $120,170 | $80,752 | $106,999 |
| Free Cash Flow | -$61,041 | -$46,987 | -$67,728 | -$134,409 |